Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
These grants were made pursuant to the Companys 2021 Inducement Stock Incentive Plan, were approved by the Companys Inducement Grant Subcommittee of the board of directors, and were made as a material inducement to each employees acceptance of employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4) as a component of his or her employment compensation.
- These grants were made pursuant to the Companys 2021 Inducement Stock Incentive Plan, were approved by the Companys Inducement Grant Subcommittee of the board of directors, and were made as a material inducement to each employees acceptance of employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4) as a component of his or her employment compensation.
- The stock options have an exercise price of $28.60 per share, equal to the closing price of Translate Bios common stock on July 6, 2021.
- The vesting of each grant is subject to the employees continued service with the Company through the applicable vesting date.
- The inducement grants are subject to the terms and conditions of award agreements covering the grants and the Companys 2021 Inducement Stock Incentive Plan.